DV Biomed Co., Ltd. (TPEX:6539)

Taiwan · Delayed Price · Currency is TWD

40.75

+0.10 (0.25%)

Sep 30, 2026, 10:26 AM CST

Market Cap	989.79M -29.6%
Revenue (ttm)	795.19M +11.6%
Net Income	76.62M +46.3%
EPS	3.15 +54.4%
Shares Out	24.35M
PE Ratio	12.86
Forward PE	n/a
Dividend	2.00 (4.91%)
Ex-Dividend Date	Aug 27, 2026

Volume	1,015
Open	40.65
Previous Close	40.65
Day's Range	40.65 - 40.75
52-Week Range	38.30 - 60.80
Beta	0.07
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About DV Biomed

DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skincare; and beauty products and services, as well as operates beauty therapy centers. The company was founded in 2011 and is based in Taipei, Taiwan. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2011

Employees 326

Stock Exchange Taipei Exchange

Ticker Symbol 6539

Full Company Profile

Financial Performance

In 2025, DV Biomed's revenue was 794.18 million, an increase of 38.46% compared to the previous year's 573.57 million. Earnings were 7.74 million, a decrease of -91.31%.

Financial Statements